PINKDX
LIVE

Serial Number

98204468

Owner

PinkDx, Inc.

Attorney

Connie L. Ellerbach

Filing Date

Sep 29, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PINKDX Trademark

Serial Number: 98204468

PINKDX is a trademark filed by PinkDx, Inc. on September 29, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

PinkDx, Inc. (2 trademarks)

9667 Deer Valley Dr.
Tallahassee, FL 32312

Entity Type: 03

Trademark Details

Filing Date

September 29, 2023

Registration Date

Not Registered

Published for Opposition

September 10, 2024

Goods & Services

Clinical research in the field of cancer and other human diseases; Medical research; Providing medical and scientific research information; Scientific research; Scientific laboratory services; Product development; Providing reagent, assay, and biological material sample testing and diagnostic services for others for scientific research and medical research; Providing online non-downloadable computer software for medical diagnostics and research

Reagents for medical and medical diagnostic use; Assays for medical and medical diagnostic use; Diagnostic preparations for medical use; Medical diagnostic preparations for RNA-based sequencing or DNA-based sequencing; Medical diagnostic preparations for bacterial detection; Diagnostic test kits for medical use comprising reagents; Medical diagnostic test kits comprised of containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, and preservatives for use in nucleic acid sequencing, genetics, and genotyping; Medical diagnostic test kits comprised of containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, and preservatives for isolating and extracting biological material and cells for genetic analysis, genotyping, and nucleic acid sequencing; biological material sample collection kits comprised of containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, and preservatives for isolating and extracting biological materials and cells for cancer detection and diagnosis; biological material sample collection kits comprised of containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, and preservatives for in vitro diagnostic testing; Cancer screening and diagnostic test kits comprised of reagents, assays, collection tubes, buffers, transport containers, and instruction sheets; biological material sample collection kits comprised of containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, and preservatives for the detection and diagnosis of cancers

Reagents for scientific, medical research, or research use, other than for medical or veterinary use; Diagnostic reagents and preparations for clinical or medical laboratory use, other than for medical or veterinary use; biological material sample collection testing kits comprised of assays and containers, plastic bags, test tubes, swabs, scrapers, needles, brushes, for scientific use or medical use research for testing human biological samples, other than for medical or veterinary use; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use, other than for medical or veterinary use

Medical services; Medical testing services related to the diagnosis and treatment of disease; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis for the diagnosis and treatment of persons; Medical diagnostic testing, monitoring, and reporting services; Genetic testing for medical purposes; Providing medical information to patients and medical professionals in the form of reports in the field of oncology, cancer, diseases, genetic analysis, nucleic acid sequencing, and genotyping; Providing reagent, assay, and biological material sample testing and diagnostic services for others for scientific research, medical research, and medical treatment purposes; Medical treatment using reagent, assay, and biological material sample testing and diagnostic services for others for medical treatment purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 24, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 24, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 24, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 1, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 1, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 20, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 19, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 19, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 19, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 17, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 17, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 17, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 27, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 26, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 26, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 7, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 7, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 7, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 7, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 7, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2024 CNRT
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
NEW APPLICATION ENTERED
Oct 3, 2023 NWAP